Submit an abstract for the ASH® Meeting on Lymphoma Biology. The deadline to submit is April 29, 2014, at 11:59 p.m. PDT.
Urge Congress to find a balanced approach to deficit reduction that does not involve further cuts to biomedical research
The American Society of Hematology (ASH) took a meaningful step toward helping facilitate more effective and patient-centered communication between primary care doctors and hematologists through a contribution to a new American College of Physicians (ACP) resource. ASH, the world’s largest professional society concerned with the causes and treatment of blood disorders, contributed several products to ACP’s High Value Care Coordination Toolkit released today and developed collaboratively through ACP’s Council of Subspecialty Societies (CSS) and patient advocacy groups.
the Centers for Medicare & Medicaid Services released a large and complex
set of data about the number and type of health-care services that individual
physicians and certain other health-care professionals delivered in 2012, and
the amount Medicare paid them for those services. The data, which cover $77 billion
of Medicare Part B Fee-for-Service program payments to 880,000 providers, are intended
to allow the public to identify outliers and patterns in payment.
New research published in Blood further illuminates the heart-healthy benefits of the Mediterranean diet, tying the eating plan to lower levels of platelets and white blood cells, two markers of inflammation.
Research published in Blood presents an unprecedented look at five unique blood cells in the human body, pinpointing the location of key genetic regulators in these cells and providing a new tool that may help scientists to identify how blood cells form and shed light on the etiology of blood diseases.
The American Society of Hematology today announced the names of 15 research investigators who will receive critical interim support from the Society.
The American Society of Hematology aims to raise awareness of potentially deadly blood clots during March – Deep-Vein Thrombosis (DVT) Awareness Month.
A pill that suppresses a key regulator of cancer growth may provide hope to relapsed leukemia and lymphoma patients running out of treatment options for their aggressive, treatment-resistant disease, according to three reports published online in Blood.
The leadership of the House Energy and Commerce and Ways and Means Committees and the Senate Finance Committee announced its agreement on legislation that would repeal the Sustainable Growth Rate.
Following a vote on Wednesday by the House of Representatives, last night the Senate approved the Consolidated Appropriations Act of 2014.
Blood Editor-in-Chief Bob Löwenberg, MD, PhD, and Deputy Editor Nancy Berliner, MD, have selected manuscripts as the most outstanding in various categories.
Urge Congress to find a balanced approach to deficit reduction that does not involve further cuts to biomedical research.
Support the mission of ASH and help move hematology forward.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology